A Trial of Lopinavir-Ritonavir in Covid-19
N Engl J Med
.
2020 May 21;382(21):e68.
doi: 10.1056/NEJMc2008043.
Epub 2020 May 5.
Authors
Alberto Carmona-Bayonas
1
,
Paula Jimenez-Fonseca
2
,
Eduardo Castañón
3
Affiliations
1
Hospital Universitario Morales Meseguer, Murcia, Spain alberto.carmonabayonas@gmail.com.
2
Hospital Universitario Central de Asturias, Oviedo, Spain.
3
Clínica Universidad de Navarra, Madrid, Spain.
PMID:
32369285
DOI:
10.1056/NEJMc2008043
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
Betacoronavirus
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy
Humans
Lopinavir
Pandemics
Pneumonia, Viral*
Ritonavir*
SARS-CoV-2
Substances
Lopinavir
Ritonavir